Matthew C. Busch insider trades

Open-market stock purchases and sales by Matthew C. Busch, VP, Finance & CAO at Amgen Inc, from SEC Form 4 filings since Nov 5, 2023.

Recent trades

DateStockTradeValue
Aug 7, 2026AMGN Amgen IncBought (not open market)—
May 7, 2026AMGN Amgen IncSold (not open market)$13.6K
May 6, 2026AMGN Amgen IncSold (not open market)$16.5K
May 5, 2026AMGN Amgen IncBought (not open market)—
May 5, 2026AMGN Amgen IncBought (not open market)$979K
May 2, 2026AMGN Amgen IncSold (not open market)$9.9K
May 2, 2026AMGN Amgen IncSold (not open market)$12.5K
Mar 16, 2026AMGN Amgen IncSold (not open market)$120K
Mar 3, 2026AMGN Amgen IncBought (not open market)—
Feb 19, 2026AMGN Amgen IncSold$376K
Nov 5, 2025AMGN Amgen IncSold (not open market)$59.9K

Companies traded

  • AMGN Amgen Inc: 2 sales, last Aug 7, 2026

Get free alerts when Matthew C. Busch files a new trade →